Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Baer

Showing results (131-140 of 628) with videos related to

Pageof 63
Sort By:
Urology|December 6, 2025
Timeline for Resolution of Hematuria Following Treatment of Urinary Tract Infection and Implications for Confirmatory TestingBlake R Baer, Meghan V Matheny, Jay D Raman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance proteinHans Minderman, Kieran L O'Loughlin, Lakshmi Pendyala, et al.
Oncogene|May 1, 1994
Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activityY Xia, L Y Hwang, M H Cobb, et al.
Biochemical Pharmacology|January 18, 2012
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceKarthika Natarajan, Yi Xie, Maria R Baer, et al.
Current Oncology Reports|July 5, 2011
Upfront therapy of acute myeloid leukemiaJenna Vanliere Canzoniero, Bhavana Bhatnagar, Maria R Baer, et al.
Journal of Oncology Practice|May 3, 2011
Part 2: implementing clinical trials: a review of the attributes of exemplary clinical trial sitesRobin Zon, Gary Cohen, Dee Anna Smith, et al.
Annals of the New York Academy of Sciences|September 29, 1995
Characterization and genomic mapping of a novel leader peptide associated with the human VH4-21 (VH4-34) gene segmentG F Widhopf, V Pascual, R Baer, et al.
Journal of Oncology Practice|November 2, 2010
Issues surrounding biospecimen collection and use in clinical trialsAllison R Baer, Mary Lou Smith, Deborah Collyar, et al.
Journal of Oncology Practice|March 2, 2011
Implementing clinical trials: a review of the attributes of exemplary clinical trial sitesAllison R Baer, Gary Cohen, Dee Anna Smith, et al.
The Journal of Biological Chemistry|March 28, 1998
Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinasesJ M English, G Pearson, R Baer, et al.
Pageof 63

Showing results (131-140 of 628) with videos related to

Sort By:
Pageof 63
Urology|December 6, 2025
Timeline for Resolution of Hematuria Following Treatment of Urinary Tract Infection and Implications for Confirmatory TestingBlake R Baer, Meghan V Matheny, Jay D Raman
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 12, 2004
VX-710 (biricodar) increases drug retention and enhances chemosensitivity in resistant cells overexpressing P-glycoprotein, multidrug resistance protein, and breast cancer resistance proteinHans Minderman, Kieran L O'Loughlin, Lakshmi Pendyala, et al.
Oncogene|May 1, 1994
Products of the TAL2 oncogene in leukemic T cells: bHLH phosphoproteins with DNA-binding activityY Xia, L Y Hwang, M H Cobb, et al.
Biochemical Pharmacology|January 18, 2012
Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistanceKarthika Natarajan, Yi Xie, Maria R Baer, et al.
Current Oncology Reports|July 5, 2011
Upfront therapy of acute myeloid leukemiaJenna Vanliere Canzoniero, Bhavana Bhatnagar, Maria R Baer, et al.
Journal of Oncology Practice|May 3, 2011
Part 2: implementing clinical trials: a review of the attributes of exemplary clinical trial sitesRobin Zon, Gary Cohen, Dee Anna Smith, et al.
Annals of the New York Academy of Sciences|September 29, 1995
Characterization and genomic mapping of a novel leader peptide associated with the human VH4-21 (VH4-34) gene segmentG F Widhopf, V Pascual, R Baer, et al.
Journal of Oncology Practice|November 2, 2010
Issues surrounding biospecimen collection and use in clinical trialsAllison R Baer, Mary Lou Smith, Deborah Collyar, et al.
Journal of Oncology Practice|March 2, 2011
Implementing clinical trials: a review of the attributes of exemplary clinical trial sitesAllison R Baer, Gary Cohen, Dee Anna Smith, et al.
The Journal of Biological Chemistry|March 28, 1998
Identification of substrates and regulators of the mitogen-activated protein kinase ERK5 using chimeric protein kinasesJ M English, G Pearson, R Baer, et al.
Pageof 63